What is the global market size of Wearable Injectors Market?

Wearable Injectors Market size was valued at USD 6.66 billion in 2021 and is poised to grow from USD 7.65 billion in 2022 to USD 23.89 billion by 2030, growing at a CAGR of 15.29% in the forecast period (2023-2030).

What is the key driver of Global Wearable Injectors Market?

The choice of different medicines and wearable drug delivery systems has increased as a result of the uncertainty surrounding the COVID-19 pandemic. To stop the illness from spreading and protect high-risk individuals from illness, medical systems on the planet have taken action to delay the onset of cancer therapies. As the pandemic spread, the risks for those obtaining medical attention increased. The majority of patients are treated in hospitals, which increased their danger during the outbreak. A shift from hospital-based therapy to home-based care has taken place in order to solve these challenges and give adequate care to individuals suffering from various illnesses.

What is the key market trend for Global Wearable Injectors Market?

The rising popularity of at-home, self-administered injectors for treating illnesses with little chance of dosage error and needle stick injuries. Other growth-promoting aspects include a number of product developments, such as the incorporation of Bluetooth, wireless communication, and passive warning systems with injectors. These innovations allow for comfortable patient monitoring via a mobile application and offer prompt medication reminders.

Which region accounted for the largest share in Global Wearable Injectors Market?

In terms of revenue, North America held the largest wearable injector market globally in 2021, and it is expected that it will continue to do so during the projection timeframe. This is explained by the spike in the number of people with various medical conditions. Furthermore, the requirement for the wearable injector market is being fueled by the introduction of numerous novel medications that may successfully cure chronic diseases. Additionally, the growing acceptance of tailored pharmaceuticals may have a favorable effect on the market in the years to come.

Top Wearable Injectors Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Wearable Injectors Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Wearable Injectors industry players.

Wearable Injectors Market Competitive Landscape

Many businesses in the market for producing wearable injectors are now concentrating on expanding their production capacities through mergers and acquisitions. For the purpose of acquiring new features or gaining entry into new markets, large primary manufacturers are creating joint ventures or purchasing small or midsized businesses. Additionally, businesses are investing in the creation of enhanced products. They are also concentrating on keeping their prices competitive. For instance, in April 2021, the Medtronic Extended infusion set is the first and only infusion set that may be worn for up to 7 days, according to an announcement made by Medtronic plc.

Top Players in the Global Wearable Injector Market

Ypsomed
Amgen
Subcuject (Denmark)
Becton, Dickinson and Company (BD)
Bespak Europe Ltd.
CeQur SA
Debiotech SA
Enable Injections
Insulet Corporation
Medtronic plc
Mylan N.V.
Nemera Development S.A.
Omron Corporation
Pfizer Inc.
Roche Holding AG
Sensile Medical AG
SteadyMed Therapeutics, Inc.
Tandem Diabetes Care, Inc.
United Therapeutics Corporation
West Pharmaceutical Services, Inc.
Zosano Pharma Corporation

Wearable Injectors Market Recent Development

In January 2022, Insulet's Omnipod 5, an automated insulin delivery system, was given the US FDA's nod. With this certification, the business hoped to launch the first wearable tubeless automated insulin administration device by fusing the Omnipod 5 with Dexcom's G6 continuous glucose monitoring system. Additionally, individuals using this device would be able to use a specialized portable remote or mobile to operate the system.
In April 2021, Five Prime Therapeutics, a clinical-stage biotechnology company that specializes in creating immuno-oncology and targeted cancer medications, has been officially acquired by Amgen. Amgen thinks that by acquiring Five Prime, it will be able to use bemarituzumab, a first-in-class treatment for gastric cancer, to help patients with stomach cancer.

REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?

REQUEST FREE CUSTOMIZATION

FAQs

Wearable Injectors Market size was valued at USD 8.82 Billion in 2024 and is poised to grow from USD 10.17 Billion in 2025 to USD 31.74 Billion by 2033, growing at a CAGR of 15.29% during the forecast period (2026–2033).

The wearable injectors market is fragmented with high competition worldwide due to the presence of major key players. These players focus on growth strategies, such as new product launches, collaborations, partnerships, business expansions, mergers & acquisitions, and patient campaigns in March 2021. Aptar and Noble International dne pharma, North European addiction treatment the first to announce a collaborative implementation the innovative Unidos Liquid system by Ventizolv, Aptar and Noble. The partnership aims to prevent the potentially deadly effects of opioid overdoses in Europe as soon as possible. 'Becton Dickinson (BD)', 'Insulet Corporation', 'Ypsomed Holding AG', 'Tandem Diabetes Care', 'Enable Injections', 'West Pharmaceutical Services', 'Stevanato Group', 'Eitan Medical', 'Sensile Medical', 'Bühler Motor', 'United Therapeutics', 'Dexcom', 'CeQur', 'Phillips-Medisize', 'Medtronic', 'Amgen', 'Oval Medical Technologies', 'Gerresheimer AG', 'Terumo Corporation', 'BioCorp'

Increasing incidence of chronic conditions such as diabetes, cardiovascular diseases and cancer is a major driver for the wearable injectors market. These devices provide a convenient and it is less painful to administer medications to patients, resulting in better patient compliance. As the global burden of chronic diseases increases, especially in the elderly population, injectable wear is expected to continue to increase.

A growing trend in the wearable injectors market is the shift towards personalized medication delivery. With more and more biopharmaceutical companies developing products tailored to individual patients, wearable injectables are increasingly being developed to meet personalized treatment regimens. This trend improves not only patient outcomes but also does accuracy, reviving the wearable injectors market demand.

North America play a dominant role in the wearable injectors market growth, each with distinctive factors driving their growth. North America especially the US. leading to improved healthcare, increasing acceptance of new technologies. In addition to the strong emphasis on home health through the presence of pharmaceutical and medtech companies, chronic diseases such as diabetes and cancer are on the way higher increases the demand for wearable injectables in this region. North America's favourable reimbursement and regulatory policies and support the region. The region is also an R&D hub, which provides technologies internal growth occurs in drug delivery systems, making it a key player in wearable injectors market growth.

Top Wearable Injectors Companies

Wearable Injectors Market Competitive Landscape

FAQs

What is the global market size of Wearable Injectors Market?

Who are the key vendors in the Wearable Injectors Market?

What is the key driver of Wearable Injectors Market?

What is the key market trend for Wearable Injectors Market?

Which region accounted for the largest share in Wearable Injectors Market?

Request Free Customization